Biocon Biologics Ltd (“BBL”) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) had issued positive ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

US president Donald Trump's imposition of import tariffs on key goods underscores his 'Made in America' agenda. While ...

In osteoporosis, bones lose minerals more than the body can replace them with new ones, leaving them thinner and more brittle. Various factors can increase your risk of developing osteoporosis, with ...

Pharma major Dr Reddy’s Laboratories Ltd’s consolidated net profit increased 21% in the fourth quarter ended March 31, 2025 ...

It would have been interesting to have sat in on the senior management meetings at Merck that thrashed out the Organon ...

Operating profit / (loss): Operating profit was $10.6 million for the three months ended 31 March 2025, compared to ($48.4) ...

Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...

President Trump touted a new Executive Order that would more closely align drug prices in the US with those sold in Europe ...

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...

Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...